Professional Summary
Professional Overview
Kim Morris is a seasoned pharmaceutical executive with over 20 years of experience in the healthcare industry. As the Vice President of Medical Affairs at Ocuphire Pharma, she oversees the company's medical strategy, medical communications, and key opinion leader engagement to drive the successful development and commercialization of innovative ophthalmic therapies.
Experience Summary
Current Role
As the Vice President of Medical Affairs at Ocuphire Pharma since 2024, Kim is responsible for leading the medical affairs team and ensuring seamless coordination with cross-functional stakeholders. She spearheads the development and implementation of comprehensive medical strategies to support the company's pipeline of novel ophthalmic products. Under her leadership, Kim has strengthened Ocuphire's relationships with key opinion leaders and established robust medical communications platforms to effectively disseminate clinical data and product information to the broader medical community.
Career Progression
Prior to her current role, Kim served as the President and Founder of Proactive Project Management, LLC, where she leveraged her expertise in medical communications and marketing to provide strategic consulting services to pharmaceutical and biotechnology companies. Before that, she held various positions at Inspire, including Director of Medical Communications and Associate Director of Marketing, where she played a pivotal role in driving the successful launch and commercialization of the company's flagship product. Kim's early career experience includes roles in marketing and market research at GlaxoSmithKline, where she honed her skills in data analysis and strategic planning.
Academic Background
Kim holds a Bachelor of Science degree in Biology from the University of North Carolina at Chapel Hill, where she graduated with honors.
Areas of Expertise
- Medical strategy development and implementation
- Medical communications and key opinion leader engagement
- Pharmaceutical marketing and product commercialization
- Project management and cross-functional collaboration
- Ophthalmic drug development and regulatory processes
Professional Impact
Throughout her career, Kim has demonstrated a track record of driving meaningful impact within the pharmaceutical industry. At Ocuphire Pharma, she has played a crucial role in advancing the company's clinical pipeline and elevating its medical affairs capabilities, resulting in enhanced visibility and credibility within the ophthalmic community. Kim's strategic leadership and collaborative approach have been instrumental in fostering strong relationships with key stakeholders and securing valuable partnerships to support Ocuphire's mission.
Conclusion
With her extensive experience, strategic mindset, and proven track record of success, Kim Morris is a valuable asset to Ocuphire Pharma and the broader pharmaceutical industry. She is poised to continue driving innovation and making a lasting impact in the field of ophthalmic drug development.